Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | — | 10.7B | 10.2B | 7.5B |
Cost of revenue | 390.6M | 402.1M | 345.9M | 362M |
Gross profit | 11.2B | 10.3B | 9.8B | 7.2B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 10.4B | 9.5B | 9.0B | 6.5B |
Operating income | — | 592.9M | 612.6M | 512.4M |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | — | 20.8M | 17.4M | 12.2M |
Other income expense | — | — | — | — |
Pretax income | 782.1M | 843.1M | 624.4M | 833.6M |
Tax provision | 235.1M | 199.1M | 149.7M | 137.3M |
Net income | 547M | 644M | 474.7M | 696.3M |
Basic EPS | — | 0.2 | 0.2 | 0.3 |
Diluted EPS | — | 0.2 | 0.2 | 0.3 |
Basic average shares | — | 2.7B | 2.6B | 2.8B |
Diluted average shares | — | 2.7B | 2.6B | 2.8B |
EBITDA | — | 1.1B | 812.9M | 1.0B |
Net income from continuing op. | — | — | — | — |
Minority interests | — | -20M | -34M | 3.9M |
Preferred stock dividends | 0 | 0 | 0 | 0 |